Cargando…

Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19

BACKGROUND: Despite a reported cardiac injury in patients with new coronavirus infection, the possibility and specifics of genuine viral myocarditis in COVID-19 remains not fully clear. PURPOSE: To study the presence of SARS-CoV-2 in the myocardium and the morphological properties of myocarditis in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kogan, Evgeniya, Berezovskiy, Yuriy, Blagova, Olga, Kukleva, Anna, Semyonova, Lyudmila, Gretsov, Evgeniy, Ergeshov, Atadzhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851780/
https://www.ncbi.nlm.nih.gov/pubmed/35177093
http://dx.doi.org/10.1186/s13000-022-01207-6
_version_ 1784652894016897024
author Kogan, Evgeniya
Berezovskiy, Yuriy
Blagova, Olga
Kukleva, Anna
Semyonova, Lyudmila
Gretsov, Evgeniy
Ergeshov, Atadzhan
author_facet Kogan, Evgeniya
Berezovskiy, Yuriy
Blagova, Olga
Kukleva, Anna
Semyonova, Lyudmila
Gretsov, Evgeniy
Ergeshov, Atadzhan
author_sort Kogan, Evgeniya
collection PubMed
description BACKGROUND: Despite a reported cardiac injury in patients with new coronavirus infection, the possibility and specifics of genuine viral myocarditis in COVID-19 remains not fully clear. PURPOSE: To study the presence of SARS-CoV-2 in the myocardium and the morphological properties of myocarditis in patients with severe coronavirus infection (COVID-19). METHODS: Autopsy data of eight elderly patients (75.6 ± 7.4 years), four male and four female, with severe new coronavirus infection were studied. The lifetime diagnosis of COVID-19 is based on a positive result of the PCR study. The inclusion criterion was the presence of morphological signs of myocarditis according to the Dallas criteria. A standard histological examination included staining by hematoxylin and eosin, toluidin blue and Van Gieson. An immunohistochemical study was performed using antibodies to CD3, CD 68, CD20, perforin, toll-like receptor (TLR) types 4 and 9. PCR in real-time was performed to determine the viral RNA in the myocardium. RESULTS: All patients had severe bilateral viral pneumonia. In all cases, myocarditis was not clinically diagnosed. Morphological examination of the heart found signs of active lymphocytic myocarditis. PCR identified the SARS-Cov2 RNA in all cases. There were also signs of destructive coronaritis in all cases, thrombovasculitis, lymphocytic pericarditis (in 3 cases) and endocarditis (in 2 cases). The absence of neutrophils confirms the aseptic nature of inflammation. An immunohistochemical study showed the CD3-positive T lymphocytes in the infiltrates. Increased expression of TLR type 4 and less 9 was also detected. CONCLUSION: Morphological and immunohistochemical evidence of myocarditis in COVID-19 was presented. Lymphocytic infiltrations and positive PCR confirm the viral nature of inflammation. Myocarditis in COVID-19 is also characterized by coronaritis with microvascular thrombosis and associated with lymphocytic endo- and pericarditis.
format Online
Article
Text
id pubmed-8851780
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88517802022-02-18 Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19 Kogan, Evgeniya Berezovskiy, Yuriy Blagova, Olga Kukleva, Anna Semyonova, Lyudmila Gretsov, Evgeniy Ergeshov, Atadzhan Diagn Pathol Short Report BACKGROUND: Despite a reported cardiac injury in patients with new coronavirus infection, the possibility and specifics of genuine viral myocarditis in COVID-19 remains not fully clear. PURPOSE: To study the presence of SARS-CoV-2 in the myocardium and the morphological properties of myocarditis in patients with severe coronavirus infection (COVID-19). METHODS: Autopsy data of eight elderly patients (75.6 ± 7.4 years), four male and four female, with severe new coronavirus infection were studied. The lifetime diagnosis of COVID-19 is based on a positive result of the PCR study. The inclusion criterion was the presence of morphological signs of myocarditis according to the Dallas criteria. A standard histological examination included staining by hematoxylin and eosin, toluidin blue and Van Gieson. An immunohistochemical study was performed using antibodies to CD3, CD 68, CD20, perforin, toll-like receptor (TLR) types 4 and 9. PCR in real-time was performed to determine the viral RNA in the myocardium. RESULTS: All patients had severe bilateral viral pneumonia. In all cases, myocarditis was not clinically diagnosed. Morphological examination of the heart found signs of active lymphocytic myocarditis. PCR identified the SARS-Cov2 RNA in all cases. There were also signs of destructive coronaritis in all cases, thrombovasculitis, lymphocytic pericarditis (in 3 cases) and endocarditis (in 2 cases). The absence of neutrophils confirms the aseptic nature of inflammation. An immunohistochemical study showed the CD3-positive T lymphocytes in the infiltrates. Increased expression of TLR type 4 and less 9 was also detected. CONCLUSION: Morphological and immunohistochemical evidence of myocarditis in COVID-19 was presented. Lymphocytic infiltrations and positive PCR confirm the viral nature of inflammation. Myocarditis in COVID-19 is also characterized by coronaritis with microvascular thrombosis and associated with lymphocytic endo- and pericarditis. BioMed Central 2022-02-17 /pmc/articles/PMC8851780/ /pubmed/35177093 http://dx.doi.org/10.1186/s13000-022-01207-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Short Report
Kogan, Evgeniya
Berezovskiy, Yuriy
Blagova, Olga
Kukleva, Anna
Semyonova, Lyudmila
Gretsov, Evgeniy
Ergeshov, Atadzhan
Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19
title Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19
title_full Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19
title_fullStr Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19
title_full_unstemmed Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19
title_short Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19
title_sort morphologically, immunohistochemically and pcr proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal covid-19
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851780/
https://www.ncbi.nlm.nih.gov/pubmed/35177093
http://dx.doi.org/10.1186/s13000-022-01207-6
work_keys_str_mv AT koganevgeniya morphologicallyimmunohistochemicallyandpcrprovenlymphocyticviralperiendomyocarditisinpatientswithfatalcovid19
AT berezovskiyyuriy morphologicallyimmunohistochemicallyandpcrprovenlymphocyticviralperiendomyocarditisinpatientswithfatalcovid19
AT blagovaolga morphologicallyimmunohistochemicallyandpcrprovenlymphocyticviralperiendomyocarditisinpatientswithfatalcovid19
AT kuklevaanna morphologicallyimmunohistochemicallyandpcrprovenlymphocyticviralperiendomyocarditisinpatientswithfatalcovid19
AT semyonovalyudmila morphologicallyimmunohistochemicallyandpcrprovenlymphocyticviralperiendomyocarditisinpatientswithfatalcovid19
AT gretsovevgeniy morphologicallyimmunohistochemicallyandpcrprovenlymphocyticviralperiendomyocarditisinpatientswithfatalcovid19
AT ergeshovatadzhan morphologicallyimmunohistochemicallyandpcrprovenlymphocyticviralperiendomyocarditisinpatientswithfatalcovid19